Stay updated on Onasemnogene for SMA: Intrathecal Clinical Trial
Sign up to get notified when there's something new on the Onasemnogene for SMA: Intrathecal Clinical Trial page.

Latest updates to the Onasemnogene for SMA: Intrathecal Clinical Trial page
- ChecktodayNo Change Detected
- Check7 days agoChange DetectedThe ClinicalTrials.gov record for the spinal muscular atrophy study is now displayed, with its study design, participant criteria, interventions, and outcome measures. It also shows that the study was terminated early and provides record history and trial documents.SummaryDifference59%

- Check14 days agoChange DetectedThe footer revision identifier changed from v3.7.2 to v3.8.0, while the page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check21 days agoChange DetectedA banner announces an NIH website terminology transition, noting that both “Artificial Intelligence” and “Super Intelligence” may appear in NIH content.SummaryDifference1%

- Check28 days agoChange DetectedThe footer’s ClinicalTrials.gov revision identifier changed from v3.7.1 to v3.7.2.SummaryDifference0.2%

- Check35 days agoChange DetectedThe footer revision number changes from v3.7.0 to v3.7.1 on the 403 Forbidden page.SummaryDifference0.2%

- Check56 days agoChange DetectedAccess to the study record is blocked by a 403 Forbidden page, replacing the expected content with an error screen. The visible header and footer indicate an access issue rather than new or updated trial information.SummaryDifference19%

Stay in the know with updates to Onasemnogene for SMA: Intrathecal Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Onasemnogene for SMA: Intrathecal Clinical Trial page.